Current Research and Developments on Thymoquinone Nanoparticles and its Health Benefits Focusing Rheumatoid Arthritis
Thymoquinone (TQ) is widely recognised as safe for use in both cosmetic and therapeutic applications within the pharmaceutical industry. For its various purposes, including scientific research, sourcing pure TQ from plants is essential. There is a growing need for advanced extraction and purification methods that align with green chemistry principles, enhancing both efficiency and safety while minimising environmental impact. A number of important studies have focused on optimising the processes of extracting and purifying TQ." We have thoroughly covered the currently available TQ extraction, synthesis, and transformation techniques in this review. Moreover, TQ"s numerous pharmacological properties against various ailments have been thoroughly investigated. Additionally, Thymoquinone (TQ) has faced challenges in pharmaceutical applications due to its low solubility and limited absorption in the human body. However, advancements in nanotechnology-based TQ formulations are offering promising solutions to improve their bioavailability and absorption efficiency. This review explores the different nanoformulations of TQ, particularly in the context of treating inflammatory conditions such as rheumatoid arthritis. It also outlines key areas of future research that could position TQ as a valuable therapeutic agent. Major Findings: This review comprehensively summarises current techniques for the extraction, synthesis, transformation, and nanoformulation of Thymoquinone (TQ), highlighting its diverse pharmacological potential despite challenges related to its low solubility and limited absorption. Advances in nanotechnology-based delivery systems show promising improvements in TQ"s bioavailability, positioning it as a strong candidate for future therapeutic applications, particularly in inflammatory disorders such as rheumatoid arthritis.